About
Small Molecule Discovery
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (34)
View allTotal Trials
34
As Lead Sponsor
28
As Collaborator
6
Total Enrollment
6,619
By Phase
PHASE2: 4PHASE4: 2PHASE1: 11PHASE1/PHASE2: 4PHASE2/PHASE3: 1PHASE3: 1
By Status
COMPLETED: 15RECRUITING: 6TERMINATED: 4ACTIVE_NOT_RECRUITING: 4APPROVED_FOR_MARKETING: 2NOT_YET_RECRUITING: 1UNKNOWN: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline31 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT07143669Lead Sponsor
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
N/ANot yet recruiting
450 participants
Started: Sep 30, 2025 · Completed: Oct 31, 2028
NCT06931405Lead Sponsor
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
PHASE2Recruiting
105 participants
Started: May 28, 2025 · Completed: Dec 31, 2026
NCT06922448Lead Sponsor
Study of BLU-808 in Allergic Rhinoconjunctivitis
PHASE2Recruiting
54 participants
Started: Apr 14, 2025 · Completed: Dec 31, 2025
NCT06748001Lead Sponsor
Avapritinib Rollover Study
PHASE4Recruiting
60 participants
Started: Nov 28, 2024 · Completed: Dec 31, 2027
NCT06948032Lead Sponsor
Study of BLU-808 in Healthy Adult Participants
PHASE1Completed
95 participants
Started: Aug 7, 2024 · Completed: Jan 21, 2025
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...